On Monday, the FTSE 100 increased after experiencing two days of decline, as global trade dynamics remained in focus. The 90-day truce between the US and China regarding trade is approaching its expiration. Previously, a May agreement saw mutual tariffs reduced from 125% to 10%, though the US maintained a 20% tariff on fentanyl imports. Investors are seeking clarity on the future direction of this complicated relationship. The pharmaceutical sector showed strong performance, with AstraZeneca rising by 1.3% and GSK advancing by 1%. Conversely, Shell and BP both experienced dips of approximately 0.5%, with oil prices declining in anticipation of the upcoming meeting between Donald Trump and Vladimir Putin. Elsewhere, Rolls-Royce executed a £4.3 billion pension pot buyout with Pension Insurance Corporation. This transaction marks the UK's largest risk-transfer deal of the year, impacting 36,000 beneficiaries and removing liabilities from Rolls-Royce's financial statements. CFO Helen McCabe described the move as a "win-win," aligning with the company's broader strategy to streamline operations.